The most frequently employed measure in attempts to alleviate symptoms and improve the quality of life of patients with chronic obstructive airways disease (COAD) is to prescribe medications. However, COAD is largely an irreversible condition and no therapeutic intervention has been shown to be universally useful. Theophylline or corticosteroid are occasionally helpful but most patients will not benefit. Of the remaining options, only oxygen has been shown to be effective in selected patients and should be administered on a continuous basis. It is becoming increasingly evident that clinicians should be more discriminating when making therapeutic decisions for persons with COAD. Maintenance therapy with pharmacological agents should be entertained only after individually conducted therapeutic trials. Moreover, enormous costs can result from treating even a small fraction of the population estimated to have COAD.
LenfantC. Lung research: Government and community. Am Rev Respir Dis1982; 26: 753–7.
2.
The health consequences of smoking—the changing cigarette.Morbid Mortal Wkly Rep1981; 30: 48–9.
3.
Highlights on the Surgeon General's report on smoking and health.Morbid Mortal Wkly Rep1979; 28: 1–12.
4.
Pulmonary terms and symbols (a report of the ACCP-ATS Joint Commission on Pulmonary Nomenclature).Chest1975; 67: 583–93.
5.
American Thoracic Society. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis1962; 85: 762–9.
6.
LaurellCBErikssonS. The electrophorectic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest1963; 15: 132–40.
7.
SniderGLSherterCBKooKWRespiratory mechanics in hamsters following treatment with endotracheal elastase or collagenase. J Appl Physiol1977; 42: 206–15.
8.
KuhnCYuSChraplyvyMThe induction of emphysema with elastase. II. Changes in connective tissue. Lab Invest1976; 34: 372–80.
9.
O'DellBLKilburnKHMcKenzieWNThe lung of the cooper-deficient rat. Am J Pathol1978; 91: 413–32.
10.
BlueMLJanoffA. Possible mechanisms of emphysema in cigarette smokers. Release of elastase from human polymorphonuclear leukocytes by cigarette smoke condensate in vitro. Am Rev Respir Dis1978; 117: 317–25.
11.
HoidalJRNiewoehnerDE. Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and hamsters. Am Rev Respir Dis1982; 126: 548–52.
12.
RodriquezRJWhiteRRSeniorRMElastase release from human alveolar macrophages: Comparison between smokers and nonsmokers. Science1977; 198: 313–4.
13.
JanoffADearingR. Alpha, -proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase. Am Rev Respir Dis1982: 126: 691–4.
14.
CarpHJanoffA. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase inhibiting capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis1978; 118: 617–21.
15.
ChowdhuryPBoneRCLouriaDBEffect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentrations. Am Rev Respir Dis1982; 126: 177–9.
16.
LeederSR. Role of infection in the cause and course of chronic bronchitis. J Infect Dis1975; 131: 731–42.
17.
ReidDDFairbairnAS. The natural history of chronic bronchitis. Lancet1958; 1: 1147–52.
18.
LeederSRWoolcockAJPeatJKAssessment of ventilatory function in an epidemiological study of Sydney school children. Bull Physiopathol Resp1974; 10: 635–41.
19.
CullenKJ. Chronic bronchitis and the Australian environment. Med J Aust1972; 1: 249–53.
20.
BeckGJDouleCASchachterEN. Smoking and lung function. Am Rev Respir Dis1981; 123: 149–55.
21.
FletcherCPetoR. The natural history of chronic airflow obstruction. Br Med J1977; 1: 1645–8.
22.
TagerISpeizerFE. Role of infection in chronic bronchitis. N Engl J Med1974; 292: 563–71.
23.
GumpDWPhillipsCAForsythBRRole of infection in chronic bronchitis. Am Rev Respir Dis1976; 113: 465–74.
24.
ReedCE. The pathogenesis of asthma. Med Clin North Am1974; 58: 55–63.
25.
KannerREMorrisAH. Clinical pulmonary function testing. In: A manual of uniform laboratory procedures for the intermountain area. Salt Lake City: Intermountain Thoracic Society, 1975: 1–12.
26.
CIBA Guest Symposium Report: Terminology, definitions, and classifications of chronic pulmonary emphysema and related conditions.Thorax1959; 14: 286–99.
27.
GrossNH. What is this thing called love? Or, defining asthma. Am Rev Respir Dis1980; 121: 203–4.
28.
DullWLBohadanaABTeculescuDBThe standard chest roentgenogram for determining lung overinflation. Lung1982; 160: 311–4.
29.
GelbAF. Physiologic diagnosis of subclinical emphysema. Am Rev Respir Dis1973; 107: 50–63.
30.
WeinbergerMHendelesL. Pharmacotherapy of asthma. Am J Hosp Pharm1976; 33: 1071–80.
31.
McElnayJCSmithGDHellingDK. A practical guide to interactions involving theophylline kinetics. Drug Intell Clin Pharm1982; 16: 533–42.
EatonMLMacDonaldFMChurchTREffects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Chest1982; 82: 538–42.
34.
AlexanderMRDullWLKasikJE. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. JAMA1980; 244: 2280–90.
35.
DullWLAlexanderMRSadoulPThe efficacy of isoproterenol inhalation for predicting the response to oral theophylline in chronic obstructive lung disease. Am Rev Respir Dis1982; 126: 656–9.
36.
EatonMLGreenBAChurchTREfficacy of theophylline in “irreversible” airflow obstruction. Ann Intern Med1980; 92: 758–61.
37.
SchmidtRAutschulerS. The usefulness of theophylline in nonasthmatic airway obstruction. Angiology1979; 30: 744–9.
38.
SacknerMA. Effects of respiratory drugs on mucociliary clearance. Chest1978; 73 (suppl): 958–66.
39.
SuttonPPPaviaDBatemanJRMThe effect of oral aminophylline on lung mucociliary clearance in man. Chest1981; 80 (suppl): 889–91.
40.
SandersJSBermanTMBartlettMMIncreased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest1980; 78: 279–82.
41.
AubierMDeTroterASampsonMAminophylline improves diaphragmatic contractility. N Engl J Med1981; 305: 249–52.
42.
SigristSThomasDHowellSThe effect of aminophylline on inspiratory muscle contractility. Am Rev Respir Dis1982; 126: 46–50.
43.
BurkiNK. Resting ventilatory pattern, mouth occlusion pressure, and the effects of aminophylline in asthma and chronic airways obstruction. Chest1979; 76: 629–35.
44.
MatthayRABergerHJLokeJEffects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease. Am J Med1978; 65: 903–10.
45.
DullWLAlexanderMRKasikJE. Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease. Am Rev Respir Dis1981; 123: 340–2.
46.
SahnSA. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest1978; 73: 389–96.
47.
MoyesENKershawRA. Long-continued treatment with tetracycline and prednisolone in chronic bronchitis. A controlled trial. Lancet1957; 2: 1187–91.
48.
MorganWKCRuscheE. A controlled trial of the effect of steroids in obstructive airways disease. Ann Intern Med1964; 61: 248–54.
49.
ShimCStoverDEWilliamsMH. Response to corticosteroids in chronic bronchitis. J Allergy Clin Immunol1978; 62: 363–7.
50.
MendellaLAManfredaJWarrenCPNSteroid response in stable chronic obstructive pulmonary disease. Ann Intern Med1982; 96: 17–21.
51.
AlbertRMartinTRLewisSW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med1980; 92: 753–8.
52.
HornHRRobinEDTheodoreJTotal eosinophil counts in the management of bronchial asthma. N Engl J Med1975; 292: 1152–5.
53.
ZussmanBM. Surveillance of ambulatory asthmatics by means of total circulating eosinophil count. Ann Allergy1978; 40: 195–9.
54.
BurrowsBHasanFMBarbeeRAEpidemiologic observations on eosinophilia and its relation to respiratory disorders. Am Rev Respir Dis1980; 122: 709–19.
55.
ElmesPCFletcherCMDuttonAAC. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis. Br Med J1957; 2: 1272–5.
56.
BerryDGFryJHindleyCPExacerbations of chronic bronchitis treatment with oxytetracycline. Lancet1960; 1: 137–9.
57.
ElmesPCKingTKCLanglandsJHMValue of arapicillin in the hospital treatment of exacerbations of chronic bronchitis. Br Med J1965; 2: 904–8.
58.
PinesARaatatHPlucinskiKAntibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis. Br Med J1968; 2: 735–8.
59.
PinesARaatatHGreenfieldJSBAntibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis. Br J Dis Chest1972; 66: 107–15.
60.
NicotraMBRiveraMAweRJ. Antibiotic therapy of acute exacerbations of chronic bronchitis: A controlled study using tetracycline. Ann Intern Med1982; 97: 18–21.
61.
FrancisRSSpicerCC. Chemotherapy in chronic bronchitis. Influence of daily penicillin and tetracycline on exacerbations and their cost. Br Med J1960; 1: 297–303.
62.
MRC Working Party. Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. Br Med J1966; 1: 1317–22.
63.
PridieRBDattaNMasseyDGA trial of continuous winter chemotherapy in chronic bronchitis. Lancet1960; 2: 723–7.
64.
DavisALGrobowEJTompsettRBacterial infection and some effects of chemoprophylaxis in chronic pulmonary emphysema. I. Chemoprophylaxis with intermittent tetracycline. Am J Med1961; 31: 365–81.
65.
DavisALGrobowEJKaminskiTBacterial infection and some effects of chemoprophylaxis in chronic pulmonary emphysema. II. Chemoprophylaxis with daily chloramphenicol. Am Rev Respir Dis1965; 92: 900–13.
66.
GoslingWRODjajadiningratRJBergsteinPGMContinuous suppressive antimicrobial treatment in chronic infected bronchitis during the winter months. Dis Chest1967; 52: 376–80.
67.
PinesA. Cephalexin in the prevention of purulent exacerbations of chronic bronchitis. Br J Clin Pract1972; 26: 209–10.
68.
DarkeCSWeberJCPBeeleyJM. Sulfametopyrazine in the prophylaxis of exacerbations of chronic bronchitis. Br J Dis Chest1972; 66: 276–83.
69.
PinesA. Trimethoprim-sulfamethoxazole in the treatment and prevention of purulene exacerbations of chronic bronchitis. J Infect Dis1973; 128: S706–9.
70.
JohnstonRNMcNeillRSSmithDHFive-year winter chemoprophylaxis for chronic bronchitis. Br Med J1969; 4: 265–9.
71.
DjajadiningratRJHroudaJGoslingWRO. The relationship and results of sputum cultures to clinical effect in a controlled trial of continuous antibiotic treatment of chronic bronchitis with dimethychlortetracycline or penicillin-V. Acta Med Scand1964; 175: 545–55.
72.
PinesA. Controlled trials of sulphonamide given weekly to prevent exacerbations of chronic bronchitis. Br. Med J1967; 3: 202–4.
73.
MurdochJMCLeckieWJHDownieJAn evaluation of continuous antibiotic therapy in chronic bronchitis. Br Med J1959; 2: 1277–85.
74.
TagerI. New antimicrobial drugs and their value in the treatment of respiratory infections (letter). Am Rev Respir Dis1978; 117: 1139.
75.
BatesJH. The role of infection during exacerbations of chronic bronchitis. Ann Intern Med1982; 97: 130–1.
76.
PetersdorfRGFeatherstoneHJ. New antimicrobial drugs and their value in the treatment of respiratory infections. Am Rev Respir Dis1978; 117: 1139–40.
77.
BurrowsBNevinW. Antibiotic management in patients with chronic bronchitis and emphysema. Ann Intern Med1972; 77: 993–5.
78.
LertzmanMMCherniackRM. Rehabilitation of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis1976; 114: 1145–65.
79.
Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstrucive lung disease: a clinical trial.Ann Intern Med1980; 93: 391–8.
80.
Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic COR pulmonale complicating chronic bronchitis and emphysema. Lancet1981; 1: 681–6.
81.
AnthonisenNR. Hypoxemia and O2 therapy. Am Rev Respir Dis1982; 126: 729–33.
82.
SchillingJPKasikJE. Intermittent positive pressure breathing: A continuing controversy. J Iowa Med Soc1980; 70: 99–103.
83.
SukumalchantraYParkSSWilliamsMH. The effect of intermittent positive pressure breathing in acute ventilatory failure. Am Rev Respir Dis1965; 92: 885–93.
84.
KamatSRDulfanoMJSegalMS. The effects of intermittent positive pressure breather (IPPB/I) with compressed air in patients with severe chronic nonspecific obstructive pulmonary disease. Am Rev Respir Dis1962; 86: 360–80.
85.
TorresGLyonsHAEmersonP. The effects of intermittent positive pressure breathing on the intrapulmonary distribution of inspired air. Am J Med1960; 29: 946–54.
86.
CherniackRMSvanhillE. Long term use of intermittent positive-pressure breathing (IPPB) in chronic obstructive pulmonary disease. Am Rev Respir Dis1976; 113: 721–8.
87.
LorenMChaiHMiklichDBarwiseG. Comparison between simple nebulization and intermittent positive pressure in asthmatic children with severe bronchospasm. Chest1977; 72: 145–7.
88.
ShimCBajwaSWilliamsMH. The effect of inhalation therapy on ventilatory function and expectoration. Chest1978; 73: 798–801.
89.
HodgkinJEBalchumDJKassIChronic obstructive airway diseases: Current concepts in diagnosis and comprehensive care. JAMA1975; 232: 1243–60.
90.
MurrayJF. The ketchup-bottle method. N Engl J Med1979; 300: 1155–57.
91.
AnthonisenPRiisPSøgaard-AndersenT. The value of lung physiotherapy in the treatment of acute exacerbations in chronic bronchitis. Acta Med Scand1964; 175: 715–9.
92.
CampbellAHO'ConnellJMWilsonF. The effect of chest physiotherapy upon FEV1 in chronic bronchitis. Med J Aust1975; 1: 33–5.
93.
NewtonDAGStephensonA. Effect of physiotherapy on pulmonary function: A laboratory study. Lancet1978; 2: 228–9.
94.
ThomanRLStokerGLRossJC. The efficacy of pursed lips breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis1966; 93: 100–6.
95.
MuellerREPettyTLFilleyGF. Ventilation and arterial blood gas changes induced by pursed lips breathing. J Appl Physiol1970; 28: 784–9.
96.
EmirgilCSobolBJNormanJA study of the long term effect therapy in chronic obstructive pulmonary disease. Am J Med1969; 47: 367–77.
97.
CampbellEJMFriendJ. Action of breathing exercises in pulmonary emphysema. Lancet1955; 1: 325–9.
98.
MillerWF. A physiological evaluation of the effects of diaphragmatic breathing training in patients with chronic pulmonary emphysema. Am J Med1954; 17: 471–7.
99.
BecklakeMRMcGregorMGoldmanHIA study of the effects of physiotherapy in chronic hypertrophic emphysema using lung function tests. Dis Chest1954; 26: 180–91.
100.
ColeMBStanskyCRobertsFEStudies in emphysema: Long-term results of training in diaphragmatic breathing on the course of obstructing emphysema. Arch Phys Med Rehabil1962; 43: 561–4.
101.
SahenSPettyTL. The results of a comprehensive rehabilitation program for severe COPD. In: PettyTL, ed. Chronic obstructive pulmonary disease. New York:Marcel Dekker, 1978: 203–20.
MarvinPMBakerBJDuttAKPhysiologic effects of oral bronchodilators during rest and exercise in chronic obstructive pulmonary disease. Chest1983; 84: 684–9.
